Yuki Noguchi
Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C. She started covering consumer health in the midst of the pandemic, reporting on everything from vaccination and racial inequities in access to health, to cancer care, obesity and mental health.
Since joining NPR in 2008, Noguchi has also covered a range of business and economic news, with a special focus on the workplace — anything that affects how and why we work. In recent years, she has covered the rise of the contract workforce, the #MeToo movement, the Great Recession and the subprime housing crisis. In 2011, she covered the earthquake and tsunami in her parents' native Japan. Her coverage of the impact of opioids on workers and their families won a 2019 Gracie Award and received First Place and Best In Show in the radio category from the National Headliner Awards. She also loves featuring offbeat topics, and has eaten insects in service of journalism.
Noguchi started her career as a reporter, then an editor, for The Washington Post.
Noguchi grew up in St. Louis, inflicts her cooking on her two boys and has a degree in history from Yale.
-
More people are getting cancer in their 20s, 30s, and 40s, and surviving, thanks to rapid advancement in care. Many will have decades of life ahead of them, which means they face greater and more complex challenges in survivorship. Lourdes Monje is navigating these waters at age 29. -
A new report shows rapid development of new cancer treatment and detection is helping people live more. But more people are also getting diagnosed, and at younger ages. -
Nearly half of women over 40 have dense breasts, which raises their risk of breast cancer. Mammograms should now include an assessment of breast tissue density. -
An additional six people have died as the toll from contamination at a single Boar's Head plant becomes the worst listeria outbreak since 2011. Listeria is a bacterial, food-borne illness.
-
Drug overdoses on college campuses are not tracked, and rarely publicized, as colleges cite health privacy laws. But advocates are working to make overdose reversal treatment widely available on campus. -
Several new studies find promising evidence that the GLP-1 class of drugs may have a cancer-preventive effect, especially for cancers linked to obesity. -
The influential US Preventive Services Task Force urged behavioral counseling for children and teens with very high BMI. Notably the group did not include Ozempic-like drugs in the recommendation. -
There are lots of reasons people have to stop taking the new weight loss drugs: cost, shortages, side effects and life events. And the weight usually comes back, doctors say. -
New measures to stop avian flu among dairy cows are taking effect, such as testing dairy herds before they cross state lines. But farmers who voluntarily report infections stand to lose money.
-
An anti-smoking advocate says the decision to leave menthol cigarettes on the market "prioritizes politics over lives, especially Black lives."
